Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States-Reference-Cited by-同舟云学术

Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States

Published:2024-03-20 Issue:4 Volume:13 Page:827-844
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Molnar Daniel^ORCID,La Elizabeth M.^ORCID,Verelst Frederik^ORCID,Poston Sara^ORCID,Graham Jonathan^ORCID,Van Bellinghen Laure-Anne^ORCID,Curran Desmond^ORCID

Funder

GlaxoSmithKline Biologicals

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-024-00939-w.pdf

Reference36 articles.

1. Coultas JA, Smyth R, Openshaw PJ. Respiratory syncytial virus (RSV): a scourge from infancy to old age. Thorax. 2019;74(10):986–93. https://doi.org/10.1136/thoraxjnl-2018-212212.

2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–59. https://doi.org/10.1056/NEJMoa043951.

3. Villanueva DH, Arcega V, Rao M. Review of respiratory syncytial virus infection among older adults and transplant recipients. Ther Adv Infect Dis. 2022;9:20499361221091412. https://doi.org/10.1177/20499361221091413.

4. Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019;366: l5021. https://doi.org/10.1136/bmj.l5021.

5. Hansen CL, Chaves SS, Demont C, Viboud C. Mortality associated with influenza and respiratory syncytial virus in the US, 1999–2018. JAMA Netw Open. 2022;5(2): e220527. https://doi.org/10.1001/jamanetworkopen.2022.0527.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel;Human Vaccines & Immunotherapeutics;2024-08-19

2. Economic burden of respiratory syncytial virus in adults in Germany – a health claims analysis between 2015 and 2018;Journal of Medical Economics;2024-08-19

3. Multiple Questions About Protection From Respiratory Syncytial Virus;Pediatric Infectious Disease Journal;2024-06-13

4. Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: a multi-model comparison;2024-05-17